Profit taking sinks Eleven Biotherapeutics

Profit taking weighed down shares of Eleven Biotherapeutics Inc. (Nasdaq: EBIO) 46 cents to close at $1.04.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.